Document:

Form of Letter Agreement, effective as of December 22, 2006

 Exhibit 10(kk) 
 December 22, 2006 
 UnitedHealth Group Incorporated 
 9900 Bren Road East 
 Minnetonka, Minnesota 55343 
 Ladies and Gentlemen: 
 This letter sets forth my agreement with UnitedHealth Group Incorporated (the
“Company”) concerning options to purchase shares of common stock of the Company granted to me by the Company which vested in 2005 or later that are potentially subject to a surtax under Section 409A of the Internal Revenue Code
of 1986 and the rules and regulations thereunder (the “Tax Code”) (the “Subject Options”). This letter agreement will be effective as of the date hereof. 
 I understand that the Company is in the process of determining, in consultation with its independent public accounting firm, the appropriate measurement
date (“Measurement Date”) for the Subject Options and that the closing price of the Company’s common stock on the Measurement Date, when finally determined, is likely to be higher than the stated exercise price of the Subject
Options. 
 I desire to reprice the Subject Options, on the terms set forth herein, to minimize, to the extent possible, any additional tax
under Section 409A of the Tax Code, with respect to the Subject Options. This letter agreement in no way constitutes an admission of wrongdoing by the Company or any other person or an admission of any knowledge that the Company’s option
administration practices were or may have been in any way deficient. 
 The Company and I agree as follows, solely to the extent required to
minimize additional tax pursuant to Section 409A of the Tax Code: 
 1. Upon determination of the appropriate Measurement Date of the
Subject Options by the Company (the “Determination Date”), the exercise price of each Subject Option that remains outstanding as of the Determination Date (each an “Outstanding Subject Option”) shall be increased to
equal the closing price of the Company’s common stock as of the Measurement Date of each such Outstanding Subject Option. If the closing price of the Company’s common stock on the Measurement Date is less than the exercise price of the
Subject Option, there shall be no adjustment to the exercise price. For the sake of clarity, in the event that certain Subject Options would not be subject to a surtax under Section 409A of the Tax Code, no adjustment will be made to such
Subject Options. 
 2. Except as set forth in this letter agreement and any prior agreements regarding my options, (including, without
limitation, the letter agreement between the 

 
Company and me dated November 7, 2006 which letter agreement shall remain in full force and effect) each outstanding option held by me as of the date
hereof shall remain outstanding, unaltered and in full force and effect. 
 3. I hereby authorize the Company to update its books and records
on the Determination Date to reflect the amendment of any option agreement or certificate pursuant to this letter agreement. I agree to make such filings on Form 4 as shall be necessary to reflect any such amendments and to take all other actions
necessary or appropriate to give effect to the foregoing. 
 4. I acknowledge and agree that to the extent that the terms of this letter
agreement may conflict with any employment agreement, option agreement or certificate or other agreement or understanding between me and the Company, whether written or oral (collectively, the “Other Agreements”), the terms of this
letter agreement shall govern. I further acknowledge and agree that, except as expressly modified by this letter agreement, all Other Agreements shall remain in full force and effect. 
 This letter agreement constitutes the entire agreement between the Company and me with respect to changes in the exercise price of my options to address Section 409A of the Tax Code and supersedes, in its
entirety, any other agreement between us, whether written or oral, relating to such matter. This agreement is intended to meet the transition relief granted by the Internal Revenue Service in Section 3.04 of IRS Notice 2006-79 and should be
interpreted in a manner in which such transition relief will be available to me so that the Subject Options shall not be subject to the provisions of section 409A for future periods. This letter agreement may not be amended or supplemented without
both my consent and the express written authorization of the Company. This letter agreement may be executed in counterparts, all of which shall constitute one instrument, and it shall be governed by the laws of the State of Minnesota, without giving
effect to the choice of law rules thereof. 
  

	
	Very truly yours,
	
	  

	[Name of Executive]

 Acknowledged and agreed effective as of the date first set forth above. 

			
	
	UNITEDHEALTH GROUP INCORPORATED
		
	By:	 	  

	Name:	 	
	Title:First Amendment to Issuing and Paying Agency Agreement

 Exhibit 10.01 
 FIRST AMENDMENT TO ISSUING AND PAYING AGENCY AGREEMENT 
 The Bank of New York, as Issuing and Paying Agent

 101 Barclay Street, Floor 8 West 
 New York, New York 10286

 Attn: Corporate Trust Administration 
  

	 	Re:	Cardinal Health, Inc.  

 Ladies and Gentlemen: 
 This letter (the “First Amendment”) sets forth the understanding between you and Cardinal Health, Inc. (the “Company”), whereby we
have agreed to amend that certain Issuing and Paying Agency Agreement by and between you and the Company dated August 9, 2006 (the “Issuing and Paying Agency Agreement”) in order to increase to $1,500,000,000 the limit as to the
aggregate principal amount of commercial paper notes which may be outstanding at any given time pursuant to such agreement. 
 1.
Defined Terms. Unless the context as used herein requires otherwise, capitalized terms used but not defined in this First Amendment shall have the meaning given to them in the Issuing and Paying Agency Agreement. 
 2. Amendment. Paragraph 4(a)(i) of the Issuing and Paying Agency Agreement is hereby deleted in its entirety and restated as follows:

 (i) date each such Certificated CP Note the date of issuance thereof (which shall be a Business Day) and insert the
maturity date thereof (provided that the Authorized Representative or Dealer Representative shall ensure that such date is a Business Day and that it shall not be more than 364 days from the date of issue and that the aggregate principal amount of
CP Notes outstanding shall not exceed $1,500,000,000) and the face amount (provided that the Authorized Representative or the Dealer Representative shall ensure that such face amount is not less than $250,000) thereof in figures; 
 3. No Other Modifications. Except as expressly provided in this First Amendment, all of the terms and conditions of the Issuing and Paying
Agency Agreement shall remain unchanged and in full force and effect. 
 4. Binding Effect. This First Amendment shall be
binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. 
 5. Governing Law.
This First Amendment shall be governed by and construed in accordance with the laws of the State of New York. 

 6. Conflict. In the event of any inconsistency or conflict between this First Amendment and
the Issuing and Paying Agency Agreement, the terms, provisions and conditions of this First Amendment shall govern and control. 
 7.
Counterparts. This First Amendment may be executed in separate counterparts, each of which shall be deemed to be an original but all of which shall constitute one and the same instrument. 
 (Signatures on following page.) 

 If the foregoing is acceptable to you, please indicate your agreement therewith by signing one or more
counterparts of this First Amendment in the space provided below, and returning such signed counterpart(s) to the Company, whereupon this letter when signed by you and the Company, will become a binding agreement between us. 
  

			
	CARDINAL HEALTH, INC.
		
	By:	 	 /s/ Linda S. Harty

	Name:	 	 Linda S. Harty, as Executive Vice
 President and
Treasurer

 Agreed to and Accepted 
 This 28th day of February, 2007 
 The Bank of New York, as Issuing and Paying Agent 
  

			
	By:	 	 /s/ Carlos R. Luciano

	Name:	 	Carlos R. Luciano
		 	Vice PresidentFirst Amendment to Commercial Paper Dealer Agreement

 Exhibit 10.02 
 FIRST AMENDMENT TO COMMERCIAL PAPER DEALER AGREEMENT 
 THIS FIRST AMENDMENT TO COMMERCIAL PAPER DEALER AGREEMENT (the “First Amendment”) is entered into on this 28th day of February, 2007 by and between Cardinal Health, Inc. (“Issuer”) and J.P. Morgan Securities, Inc. (“Dealer”). 
 Background Information 
 A. Issuer and Dealer are parties to that certain
Commercial Paper Dealer Agreement dated August 9, 2006 (the “Agreement”) concerning notes issued pursuant to that certain Issuing and Paying Agency Agreement also dated August 9, 2006 by and between Issuer and The Bank of New
York (the “Issuing and Paying Agency Agreement”). 
 B. The Issuer desires to increase to $1,500,000,000 the limit as to the
aggregate principal amount of commercial paper notes which may be outstanding at any given time under the 4(2) Commercial Paper Program established by the Issuing and Paying Agency Agreement, the Agreement, and other related agreements. 

Agreement 
 The parties
hereby acknowledge the accuracy of the foregoing Background Information and agree as follows: 
 1. Defined Terms. Unless the
context as used herein requires otherwise, capitalized terms used but not defined in this First Amendment shall have the meaning given to them in the Agreement. 
 2. Amendment. The centered paragraph underneath the line on page one (the cover page) of the Agreement is hereby deleted in its entirety and restated as follows: 
 Between: Cardinal Health, Inc., as Issuer and J.P. Morgan Securities, Inc., as Dealer Concerning Notes to be issued pursuant to an Issuing and Paying
Agency Agreement dated as of August 9, 2006, as amended February 28, 2007, between the Issuer and the Bank of New York, as Issuing and Paying Agent, Dated as of August 9, 2006, as amended February 28, 2007. 
 3. No Other Modifications. Except as expressly provided in this First Amendment, all of the terms and conditions of the Agreement shall
remain unchanged and in full force and effect. 
 4. Binding Effect. This First Amendment shall be binding upon and inure to
the benefit of the parties hereto and their respective successors and assigns. 

 5. Governing Law. This First Amendment shall be governed by and construed in accordance
with the laws of the State of New York. 
 6. Conflict. In the event of any inconsistency or conflict between this First
Amendment and the Agreement, the terms, provisions and conditions of this First Amendment shall govern and control. 
 7.
Counterparts. This First Amendment may be executed in separate counterparts, each of which shall be deemed to be an original but all of which shall constitute one and the same instrument. 
 (Signatures on following page.) 

 The parties hereto have executed this First Amendment as of the day and year first written above.

  

							
	CARDINAL HEALTH, INC.	 	J.P. MORGAN SECURITIES, INC.
				
	By:	 	 /s/ Linda S. Harty
	 	By:	 	 /s/ Johanna C. Foley

	Name:	 	Linda S. Harty, as Executive	 	Name:	 	Johanna C. Foley
		 	Vice President and Treasurer	 		 	
				
	Date:	 	2-28-2007	 	Date:	 	Feb. 28, 2007

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}]]